[Therapeutic orientation in the hyperlipidemias].
D002792:Cholestyramine Resin / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D006949:Hyperlipidemias / Q000145:classification / Q000178:diet therapy / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008074:Lipoproteins / Q000032:analysis / Q000145:classification; D009355:Neomycin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010074:Oxandrolone / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D012855:Sitosterols / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D008074:Lipoproteins; D009539:Nicotinic Acids; D012855:Sitosterols; D014280:Triglycerides; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D010074:Oxandrolone; D009355:Neomycin; D011341:Probucol
Orientação terapêutica nas hiperlipidemias.